GT Apeiron Therapeutic
Latest round
- Angel
Last raised
- Jun 2019
Total raised
- $27M
Investors
- 1
About GT Apeiron Therapeutic
Established in 2019 and based in Shanghai, China, GT Apeiron Therapeutic is a drug development company that focuses on the development of antitumor drugs via artificial intelligence(AI) technology.
Who invested in GT Apeiron Therapeutic
1 investor across 1 round
See all investors in GT Apeiron Therapeutic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jun 12, 2019
Amount
$27M
Investors
Questions about GT Apeiron Therapeutic
Who invested in GT Apeiron Therapeutic?
GT Apeiron Therapeutic has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GT Apeiron Therapeutic raised?
GT Apeiron Therapeutic has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did GT Apeiron Therapeutic last raise money?
GT Apeiron Therapeutic's most recent round on record is a Angel, in Jun 2019.
What does GT Apeiron Therapeutic do?
Established in 2019 and based in Shanghai, China, GT Apeiron Therapeutic is a drug development company that focuses on the development of antitumor drugs via artificial intelligence(AI) technology.
Where is GT Apeiron Therapeutic headquartered?
GT Apeiron Therapeutic is headquartered in Shanghai, China.
Which VCs invest in companies like GT Apeiron Therapeutic?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at GT Apeiron Therapeutic's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like GT Apeiron Therapeutic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.